EPTIS
BAM Logo

Virus Genome Detection – Coronaviruses incl. SARS-CoV-2 (340)

[Virusgenom-Nachweis – Coronaviren inkl. SARS-CoV-2 (340)]

EPTIS factsheet 437169 | Last revision 2024-04-16 | URL: https://www.eptis.bam.de/pts437169 https://www.eptis.bam.de/pts437169

PT provider
PT provider INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
Based in Germany
Language(s) German, English
Remarks Infectious material, UN3373, biological substances category B. Note for laboratories from non-EU countries: The shipment of sample materials for participation in this EQA scheme is subject to a release by the Federal Office of Economic Affairs and Export Control according to the EU Dual-Use Regulation (VO (EU) 2021/821) for sample recipients in non-EU countries. INSTAND e.V. can only process EQA scheme orders from non-EU countries if the ordering laboratories provide a completed end-use certificate, company profile including contact details (e.g. excerpt from website) and, if applicable, an import permit! Failure to provide completed documents by the ordering deadline will unfortunately lead to the cancellation of your registration The interdisciplinary, non-profit, scientific and medical association INSTAND e. V. is a reference institution for the quality control of medical laboratories. It is one of four German reference institutions responsible for the organization of external quality assessment (EQA) schemes for quality control in medical laboratories. You can register for EQAs, submit your results and later download your evaluation documents via https://rv-online.instandev.de. This price applies exclusively to orders placed via INSTAND e.V. Prices and services may differ for orders placed via distributors. Our newest EQA program can also be found on our website: https://www.instand-ev.de/en/instand-eqas/eqa-program/ Cooperation with: Nationales Konsiliarlabor für Coronaviren, Institut für Virologie, Charité – Universitätsmedizin Berlin; Institut für Medizinische Virologie, Uniklinikum Frankfurt am Main
Keywords
Product groups Human test material
Testing fields Medical analysis
Technical details
Test item Tested property Testing method
6 samples of 1.5 mL lyophilised cell culture lysates Polymerase chain reaction (PCR) and other nucleic acid amplification techniques (NAT) for SARS-CoV-2- RNA, MERS-CoV-RNA and other human coronavirus RNA -
Option for differentiaton between SARS-CoV-2, MERS-CoV and other human coronaviruses (samples which contain SARS-CoV-2 and MERS-CoV, repectively, are inactivated -
Aims of the PT scheme
Target group of participants
Linked to specific legislation / standards
Additional, subsidiary aims
Number of participants 250-500
Accredited or otherwise reviewed by a 3rd party

Accredited by DAkkS (Germany) on the basis of ISO/IEC 17043

German Bundesärztekammer (General medical Council)

Operation is commissioned / requested by German Bundesärztekammer (General medical Council)
Fees and frequency
Participation fee 378 € / Survey
Regularly operated Yes (2 times per year)
Year of first operation Experience with operation of ILCs since 1968
Contact details of the PT provider
Provider Contact person
INSTAND e.V., Society for Promoting Quality Assurance in Medical Laboratories
P.O.Box 250211, Ubierstrasse 20
40223 Düsseldorf
Germany

Phone: +49-211-159213-0
Fax:
Web: http://www.instandev.de/ http://www.instandev.de/
Dr. rer. nat. Nathalie Weiss
Phone: +49-211-159213430
Fax:
Email: weiss@instand-ev.de weiss@instand-ev.de
If you find any mistakes please contact the responsible EPTIS coordinator in Germany, Mr Johannes van de Kreeke. Mr Johannes van de Kreeke.
Any questions or problems? Please contact us at eptis@bam.de.
Application version: 1.23-SNAPSHOT.20230502124635-7925ae379a631fc1ececff45d2921c8db38877d5